Publicaciones (160) Publicaciones de Francisco Javier Escalada San Martín

2025

  1. Prevalence of obesity and diabetes in Spain. Evolution in the last 10 years

    Atencion Primaria, Vol. 57, Núm. 3

2024

  1. Cardiometabolic risk stratification using a novel obesity phenotyping system based on body adiposity and waist circumference

    European Journal of Internal Medicine, Vol. 124, pp. 54-60

  2. Decreased expression of the NLRP6 inflammasome is associated with increased intestinal permeability and inflammation in obesity with type 2 diabetes

    Cellular and Molecular Life Sciences, Vol. 81, Núm. 1

  3. Drug approach to treatment for obesity in adults: perspectives and considerations

    Revista Espanola de Enfermedades Digestivas

  4. Enhancing the management of chronic diseases in clinical practice: The CARABELA methodology

    Journal of Healthcare Quality Research, Vol. 39, Núm. 5, pp. 336-339

  5. Epicardial and liver fat implications in albuminuria: a retrospective study

    Cardiovascular Diabetology, Vol. 23, Núm. 1

  6. FNDC4 reduces hepatocyte inflammatory cell death via AMPKα in metabolic dysfunction-associated steatotic liver disease

    Clinical Nutrition, Vol. 43, Núm. 9, pp. 2221-2233

  7. Glucometrics knowledge and its relationship to glycemic control in people living with type 1 diabetes: The GluKometrics study: Glucometrics knowledge and glycemic control in type 1 diabetes.

    Diabetes and Metabolism

  8. Increased expression of IL-1β in adipose tissue in obesity influences the development of colon cancer by promoting inflammation

    Journal of Physiology and Biochemistry

  9. Metabolic dysfunction-associated steatohepatitis (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) require urgent attention by primary care physicians and endocrinologists

    Endocrinologia, Diabetes y Nutricion, Vol. 71, Núm. 4, pp. 149-151

  10. Multidisciplinary Delphi consensus on challenges and key factors for an optimal care model in chronic kidney disease

    Nefrologia, Vol. 44, Núm. 5, pp. 678-688

  11. Super response to liraglutide in people with obesity: A case report and literature review

    Endocrinologia, Diabetes y Nutricion

  12. The role of basal insulins in the treatment of people with type 2 diabetes and chronic kidney disease: A narrative review

    Diabetes, Obesity and Metabolism, Vol. 26, Núm. 4, pp. 1157-1170

2023

  1. A survey on the perception of the specialty of Endocrinology and Nutrition among students preparing for the entrance exam for medical specialty training in Spain

    Endocrinologia, Diabetes y Nutricion, Vol. 70, Núm. 4, pp. 240-244

  2. Antagonic effect of ghrelin and LEAP-2 on hepatic stellate cell activation and liver fibrosis in obesity-associated nonalcoholic fatty liver disease

    European journal of endocrinology, Vol. 188, Núm. 7, pp. 564-577

  3. Antidiabetic Drugs That Reduce Weight and Are Cardioprotective

    Handbook of Obesity - Volume 2: Clinical Applications, Fifth Edition (CRC Press), pp. 318-332

  4. BMI-based obesity classification misses children and adolescents with raised cardiometabolic risk due to increased adiposity

    Cardiovascular Diabetology, Vol. 22, Núm. 1

  5. Comprehensive approach to people with type 2 diabetes. Diabetes Knowledge Area of the Spanish Society of Endocrinology and Nutrition

    Endocrinologia, Diabetes y Nutricion, Vol. 70, pp. 95-102

  6. Evaluation of Dietary and Alcohol Drinking Patterns in Patients with Excess Body Weight in a Spanish Cohort: Impact on Cardiometabolic Risk Factors

    Nutrients, Vol. 15, Núm. 22

  7. Glycaemic Control and Weight Reduction: A Narrative Review of New Therapies for Type 2 Diabetes

    Diabetes Therapy, Vol. 14, Núm. 11, pp. 1771-1784